ZUMA-7 Archives - Medical Conferences

Axi-cel superior to standard-of-care in older patients with relapsed/refractory large B-cell lymphoma

Presented By

Dr Anna Sureda, University of Barcelona, Spain

Trial

Phase 3, ZUMA-7

Conference

EHA 2022

Type

News article

1 July 2022 11:40

Axi-cel improved event-free survival in R/R DLBCL

Presented By

Dr Frederick Locke, Moffitt Cancer Cancer, FL, USA

Trial

Phase 3, ZUMA-7

Conference

ASH 2021

Type

Peer-reviewed article

4 February 2022 11:09

Axi-cel improved event-free survival in relapsed/refractory large B-cell lymphoma

Expert

Dr Frederick Locke, Moffitt Cancer Cancer, Tampa, Florida, USA

Trial

Phase 3, ZUMA-7

Conference

ASH 2021

Type

News article

4 February 2022 10:10

Improved QoL with axi-cel versus standard-of-care in R/R LBCL

Expert

Dr Mahmoud Elsawy, Dalhousie University, Halifax, USA

Trial

Phase 3, ZUMA-7

Conference

ASH 2021

Type

News article

4 February 2022 09:48

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com